WiDesAI (kiWI Desi AI Bot) The fifth annual UAE International Conference in Nuclear Medicine, held in Dubai, concluded with a strong call for expanding the use of modern technologies in the field, particularly for cancer diagnosis and treatment. Participants, representing the Arab Society for Nuclear Medicine, emphasized the need for specialized training and qualification programs for medical staff to keep pace with advancements in nuclear medicine.
The conference highlighted the transformative potential of molecular imaging and radioisotope radiotherapy in personalized healthcare. These techniques offer targeted treatment options that minimize side effects by focusing on infected cells while sparing healthy tissues. This, in turn, increases the success rates of therapies.
Batoul Al Balooshi, Assistant Professor of Nuclear Medicine at Mohammed Bin Rashid University of Medicine and Health Sciences, highlighted the success of advanced nuclear medicine techniques in treating 15 patients with prostate and endocrine tumors, achieving complete tumor control in all cases. She emphasized the effectiveness of nuclear medicine as a cornerstone of modern personalized medicine, integrating accurate diagnosis with targeted therapy to enhance recovery and improve quality of life for patients.
The UAE boasts a robust infrastructure for nuclear medicine, with 14 specialized centers distributed across various emirates, equipped with the latest technologies and devices. This positions the UAE as a regional leader in this field.
The conference delved into specific advancements in nuclear medicine, including:
- Thyroid cancer treatment: The conference discussed the importance of diagnostic therapy “Thyranostix” and explored methods for managing differentiated thyroid cancer after radioactive iodine therapy, including potential complications and their management.
- Prostate cancer treatment: The conference explored the use of targeted radiotherapy for prostate cancer, reviewing innovative concepts using new analogues to image and treat PSMA receptors. The role of Lu-PSMA 617 in treating advanced cases was discussed, as well as a scientific comparison between Lu-177 and TB-161 as promising treatment options.
The experts concluded the conference by emphasizing the importance of supporting joint scientific research, strengthening regional and international cooperation, and launching initiatives to raise public awareness about the role of nuclear medicine in early disease detection and effective treatment.
This conference underscores the UAE’s commitment to advancing healthcare through cutting-edge technologies and promoting the use of nuclear medicine as a vital tool in the fight against cancer and other chronic diseases. The conference serves as a platform for sharing knowledge, fostering collaboration, and driving innovation in the field.
